@ARTICLE{
author={Lentz Steven R,Janic Dragana M,Kavakli Kaan,Miljic Predrag S,Oldenburg Johannes,Ozelo Margareth Castro,Santagostino Elena,Suzuki Takashi,Zupancic-Salek Silva,Korsholm Lars,Matytsina Irina,Tiede Andreas},
year={2018},
title={Long-term safety and efficacy of turoctocog alfa in prophylaxis and treatment of bleeding episodes in severe haemophilia A: Final results from the guardian 2 extension trial},
journal={HAEMOPHILIA},
volume={24},
number={6},
pages={E391-E394},
document_type={Article},
} 

@ARTICLE{
author={Janic Dragana M,Karim Faraizah Abdul,Matytsina Irina,Ozelo Margareth Castro,Savic Aleksandar D,Tiede Andreas,Oldenburg Johannes},
year={2016},
title={Efficacy and safety of turoctocog alfa for prophylaxis and treatment of bleeding episodes in patients with severe hemophilia A: results from the guardian (TM) 2 trial},
journal={HAEMOPHILIA},
volume={22},
number={},
pages={48-48},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Ozelo Margareth Castro,Janic Dragana M,Matytsina Irina,Landorph Andrea,Zeuthan Niels,Santagostino Elena},
year={2014},
title={Changes in Annualized Bleeding Rate over Time and Relationship with Dosing of Turoctocog Alfa during the guardian(TM) Program},
journal={BLOOD},
volume={124},
number={21},
pages={-},
document_type={Meeting Abstract},
}